These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21400677)

  • 1. Genetic manipulation of Clostridium difficile.
    Bouillaut L; McBride SM; Sorg JA
    Curr Protoc Microbiol; 2011 Feb; Chapter 9():Unit 9A.2. PubMed ID: 21400677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a non-sporulating secondary phenotype in Clostridium (Clostridioides) difficile ribotype 078 isolated from humans and animals.
    Connor MC; McGrath JW; McMullan G; Marks N; Guelbenzu M; Fairley DJ
    Sci Rep; 2019 Sep; 9(1):13722. PubMed ID: 31548637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock increases conjugation efficiency in Clostridium difficile.
    Kirk JA; Fagan RP
    Anaerobe; 2016 Dec; 42():1-5. PubMed ID: 27377776
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Coullon H; Rifflet A; Wheeler R; Janoir C; Boneca IG; Candela T
    J Biol Chem; 2018 Nov; 293(47):18040-18054. PubMed ID: 30266804
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Weese JS
    J Vet Diagn Invest; 2020 Mar; 32(2):213-221. PubMed ID: 31904312
    [No Abstract]   [Full Text] [Related]  

  • 6. Heme sensing and detoxification by HatRT contributes to pathogenesis during Clostridium difficile infection.
    Knippel RJ; Zackular JP; Moore JL; Celis AI; Weiss A; Washington MK; DuBois JL; Caprioli RM; Skaar EP
    PLoS Pathog; 2018 Dec; 14(12):e1007486. PubMed ID: 30576368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Markerless Deletions in the Nosocomial Pathogen
    Theophilou ES; Vohra P; Gallagher MP; Poxton IR; Blakely GW
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478235
    [No Abstract]   [Full Text] [Related]  

  • 8. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.
    Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB
    Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culturing and maintaining Clostridium difficile in an anaerobic environment.
    Edwards AN; Suárez JM; McBride SM
    J Vis Exp; 2013 Sep; (79):e50787. PubMed ID: 24084491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary dynamics of Clostridium difficile over short and long time scales.
    He M; Sebaihia M; Lawley TD; Stabler RA; Dawson LF; Martin MJ; Holt KE; Seth-Smith HM; Quail MA; Rance R; Brooks K; Churcher C; Harris D; Bentley SD; Burrows C; Clark L; Corton C; Murray V; Rose G; Thurston S; van Tonder A; Walker D; Wren BW; Dougan G; Parkhill J
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7527-32. PubMed ID: 20368420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile.
    Müh U; Pannullo AG; Weiss DS; Ellermeier CD
    J Bacteriol; 2019 Jul; 201(14):. PubMed ID: 30745377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An
    Hornung BVH; Kuijper EJ; Smits WK
    Microb Genom; 2019 Sep; 5(9):. PubMed ID: 31526450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the Anaerobic Enteropathogen
    Kint N; Alves Feliciano C; Martins MC; Morvan C; Fernandes SF; Folgosa F; Dupuy B; Texeira M; Martin-Verstraete I
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900801
    [No Abstract]   [Full Text] [Related]  

  • 14. SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins.
    Putnam EE; Nock AM; Lawley TD; Shen A
    J Bacteriol; 2013 Mar; 195(6):1214-25. PubMed ID: 23292781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array comparative hybridisation reveals a high degree of similarity between UK and European clinical isolates of hypervirulent Clostridium difficile.
    Marsden GL; Davis IJ; Wright VJ; Sebaihia M; Kuijper EJ; Minton NP
    BMC Genomics; 2010 Jun; 11():389. PubMed ID: 20565959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of functionality of type II toxin-antitoxin systems of Clostridioides difficile R20291.
    Álvarez R; Ortega-Fuentes C; Queraltó C; Inostroza O; Díaz-Yáñez F; González R; Calderón IL; Fuentes JA; Paredes-Sabja D; Gil F
    Microbiol Res; 2020 Oct; 239():126539. PubMed ID: 32622285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.
    Lynch T; Chong P; Zhang J; Hizon R; Du T; Graham MR; Beniac DR; Booth TF; Kibsey P; Miller M; Gravel D; Mulvey MR;
    PLoS One; 2013; 8(1):e53757. PubMed ID: 23349739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Shrestha R; Lockless SW; Sorg JA
    J Biol Chem; 2017 Jun; 292(25):10735-10742. PubMed ID: 28487371
    [No Abstract]   [Full Text] [Related]  

  • 19. A Revised Understanding of Clostridioides difficile Spore Germination.
    Lawler AJ; Lambert PA; Worthington T
    Trends Microbiol; 2020 Sep; 28(9):744-752. PubMed ID: 32781028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function σ factors in Clostridium difficile.
    Ho TD; Ellermeier CD
    Infect Immun; 2011 Aug; 79(8):3229-38. PubMed ID: 21628514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.